Menu
GWAS Study

Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate.

Mishra A, Duplaà C, Vojinovic D et al.

35511193 PubMed ID
GWAS Study Type
19721 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MA
Mishra A
DC
Duplaà C
VD
Vojinovic D
SH
Suzuki H
SM
Sargurupremraj M
ZN
Zilhão NR
LS
Li S
BT
Bartz TM
JX
Jian X
ZW
Zhao W
HE
Hofer E
WK
Wittfeld K
HS
Harris SE
VD
van der Auwera-Palitschka S
LM
Luciano M
BJ
Bis JC
AH
Adams HHH
SC
Satizabal CL
GR
Gottesman RF
GP
Gampawar PG
BR
Bülow R
WS
Weiss S
YM
Yu M
BM
Bastin ME
LO
Lopez OL
VM
Vernooij MW
BA
Beiser AS
VU
Völker U
KT
Kacprowski T
SA
Soumare A
SJ
Smith JA
KD
Knopman DS
MZ
Morris Z
ZY
Zhu Y
RJ
Rotter JI
DC
Dufouil C
VH
Valdés Hernández M
MM
Muñoz Maniega S
LM
Lathrop M
BE
Boerwinkle E
SR
Schmidt R
IM
Ihara M
MB
Mazoyer B
YQ
Yang Q
JA
Joutel A
TE
Tournier-Lasserve E
LL
Launer LJ
DI
Deary IJ
MT
Mosley TH
AP
Amouyel P
DC
DeCarli CS
PB
Psaty BM
TC
Tzourio C
KS
Kardia SLR
GH
Grabe HJ
TA
Teumer A
VD
van Duijn CM
SH
Schmidt H
WJ
Wardlaw JM
IM
Ikram MA
FM
Fornage M
GV
Gudnason V
SS
Seshadri S
MP
Matthews PM
LW
Longstreth WT
CT
Couffinhal T
DS
Debette S
Chapter II

Abstract

Summary of the research findings

Cerebral small vessel disease is a leading cause of stroke and a major contributor to cognitive decline and dementia, but our understanding of specific genes underlying the cause of sporadic cerebral small vessel disease is limited. We report a genome-wide association study and a whole-exome association study on a composite extreme phenotype of cerebral small vessel disease derived from its most common MRI features: white matter hyperintensities and lacunes. Seventeen population-based cohorts of older persons with MRI measurements and genome-wide genotyping (n = 41 326), whole-exome sequencing (n = 15 965), or exome chip (n = 5249) data contributed 13 776 and 7079 extreme small vessel disease samples for the genome-wide association study and whole-exome association study, respectively. The genome-wide association study identified significant association of common variants in 11 loci with extreme small vessel disease, of which the chr12q24.11 locus was not previously reported to be associated with any MRI marker of cerebral small vessel disease. The whole-exome association study identified significant associations of extreme small vessel disease with common variants in the 5' UTR region of EFEMP1 (chr2p16.1) and one probably damaging common missense variant in TRIM47 (chr17q25.1). Mendelian randomization supports the causal association of extensive small vessel disease severity with increased risk of stroke and Alzheimer's disease. Combined evidence from summary-based Mendelian randomization studies and profiling of human loss-of-function allele carriers showed an inverse relation between TRIM47 expression in the brain and blood vessels and extensive small vessel disease severity. We observed significant enrichment of Trim47 in isolated brain vessel preparations compared to total brain fraction in mice, in line with the literature showing Trim47 enrichment in brain endothelial cells at single cell level. Functional evaluation of TRIM47 by small interfering RNAs-mediated knockdown in human brain endothelial cells showed increased endothelial permeability, an important hallmark of cerebral small vessel disease pathology. Overall, our comprehensive gene-mapping study and preliminary functional evaluation suggests a putative role of TRIM47 in the pathophysiology of cerebral small vessel disease, making it an important candidate for extensive in vivo explorations and future translational work.

19,721 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

19721
Total Participants
GWAS
Study Type
No
Replicated
European, African American or Afro-Caribbean
Ancestry
Austria, Netherlands, U.S., U.K., France, Iceland, Germany
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.